Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com.
Brands: https://events.jspargo.com/ASCO21/CUSTOM/Epizyme%20Banner%201140x250.png
https://www.youtube.com/watch?v=iG7YjQnIMLc
https://youtu.be/JQsDYG7iTcU
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30451-4/fulltext
https://www.tazverik.com/Content/pdf/prescribing-information.pdf
Toll-Free in the U.S.: 1-866-4EPZMED
medinfo@epizyme.com
Contact this Exhibitor